Cc1cc(C2=NN=C(NCCc3ccccc3)SC2)c(C)n1-c1c(C)n(C)n(-c2ccccc2)c1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?